Understanding the mechanisms of ESX secretion systems in mycobacteria
了解分枝杆菌 ESX 分泌系统的机制
基本信息
- 批准号:10756076
- 负责人:
- 金额:$ 4.39万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2024-08-31
- 项目状态:已结题
- 来源:
- 关键词:ATP phosphohydrolaseAntibioticsBacteriaBiological AssayCause of DeathCellular biologyComplementComplexCore ProteinCryoelectron MicroscopyCytoplasmic TailDataDevelopmentDiseaseDominant-Negative MutationELF3 geneElectron MicroscopyExhibitsGelGeneticGenus MycobacteriumGoalsGrantGrowthHomeostasisHomologous ProteinImmune mediated destructionImmune systemImmunoprecipitationIn VitroIndividualInfectionInfectious AgentIntegral Membrane ProteinIronIron Chelating AgentsIron ChelationKnock-outKnowledgeLinkMembraneMembrane ProteinsModelingMolecularMolecular ConformationMotionMotorMulti-Drug ResistanceMutateMutationMycobacterium smegmatisMycobacterium tuberculosisNegative StainingOperonPathogenicityPersonsPhagocytesPhenotypePositioning AttributeProcessProteinsPublishingResolutionRoleSignal TransductionStructureSystemTRAP ComplexTertiary Protein StructureTestingTuberculosisVariantVirulenceWorkanalogdimerflexibilityinsightiron supplementationmembermodel organismmonomermutantmutation screeningmycobacterialnovelnovel therapeuticsoverexpressionpathogenpreventprotein complexsmall moleculestructural biologytool
项目摘要
PROJECT SUMMARY
Mycobacterium tuberculosis is the causative agent of tuberculosis, a disease that takes the lives of millions of
people annually. With the rise of multidrug resistant mycobacteria there is a dire need for development of new
antibiotics and therapies. The ESX-3 secretion system is an attractive target, as it is required for the selection
and release of various M. tuberculosis substrates and is required for iron acquisition and homeostasis. This latter
role is essential in M. tuberculosis, such that if ESX-3 is knocked out the bacteria will not survive in vitro without
excess iron supplementation. Development of a new therapeutic, such as a small molecule that prevents the
secretion mechanism underpinning the function of the complex, requires an understanding of the ESX-3
structure. The Rosenberg lab has determined the structure of the model organism M. smegmatis ESX-3
secretion system using cryo-electron microscopy. M. smegmatis is a nonpathogenic, fast growing
mycobacterium that expresses ESX proteins homologous to M. mycobacterium. The cryo-EM structure has
provided novel insight into how ESX-3 complexes oligomerize, as well as how the individual components that
comprise the ESX-3 complex interact with one another. Based on our structure, which we believe is the complex
trapped in the "off" state, I hypothesize that substrate secretion through ESX-3 is modulated by changes in the
molecular configuration of the machine. In Aim 1, I will use a combination of mycobacterial genetics, structural
biology, and cryo-EM to trap the ESX-3 complex in an alternative, active state that will inform how the complex
rearranges during secretion. In Aim 2, I will use deep mutational scanning and a survival assay I developed to
further investigate the importance and function of the core ESX-3 proteins using the previously mentioned low-
iron growth phenotype, where if an essential protein, protein domain, or protein residue is mutated, the bacteria
will not survive in chelated iron media. Taken together, these aims will allow me to study the ESX-3 secretion
mechanism and determine which intra-complex interactions are required to facilitate this mechanism. These
studies may identify new targets to develop novel antibiotics and might also provide a better understanding of
the cell biology of mycobacteria.
项目摘要
结核分枝杆菌是结核病的病原体,结核病是一种夺去数百万人生命的疾病。
人每年。随着多药耐药分枝杆菌的增加,迫切需要开发新的抗结核药物。
抗生素和治疗。ESX-3分泌系统是一个有吸引力的目标,因为它是选择所需的。
和释放各种M.结核病的底物和所需的铁的收购和稳态。后一
在M.结核病,使得如果ESX-3被敲除,细菌将不能在体外存活,
过量补铁开发一种新的治疗方法,如一种小分子,
支持复合物功能的分泌机制,需要了解ESX-3
结构罗森伯格实验室已经确定了模式生物M的结构。斯美拉ESX-3
使用冷冻电子显微镜观察分泌系统。M.包皮垢病是一种非致病性的,快速生长的
表达与分枝杆菌同源的ESX蛋白的分枝杆菌。分枝杆菌该冷冻EM结构具有
提供了新的见解ESX-3复合物如何寡聚化,以及如何单独的组件,
包括ESX-3复合体相互作用。根据我们的结构,我们认为这是复杂的
在“关闭”状态下,我假设通过ESX-3的底物分泌是由
机器的分子结构在目标1中,我将使用分枝杆菌遗传学、结构
生物学和cryo-EM将ESX-3复合体捕获在另一种活跃的状态下,
分泌期间重新排列。在目标2中,我将使用深度突变扫描和我开发的存活测定,
进一步研究核心ESX-3蛋白的重要性和功能,使用先前提到的低-
铁生长表型,其中如果必需蛋白质、蛋白质结构域或蛋白质残基突变,则细菌
不能在螯合铁介质中存活综上所述,这些目标将使我能够研究ESX-3分泌
机制,并确定需要哪些复合体内的相互作用来促进这种机制。这些
研究可能会发现新的目标,以开发新的抗生素,也可能提供更好的理解,
分枝杆菌的细胞生物学
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Donovan David Trinidad其他文献
Donovan David Trinidad的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Donovan David Trinidad', 18)}}的其他基金
Understanding the mechanisms of ESX secretion systems in mycobacteria
了解分枝杆菌 ESX 分泌系统的机制
- 批准号:
10155312 - 财政年份:2021
- 资助金额:
$ 4.39万 - 项目类别:
Understanding the mechanisms of ESX secretion systems in mycobacteria
了解分枝杆菌 ESX 分泌系统的机制
- 批准号:
10505842 - 财政年份:2021
- 资助金额:
$ 4.39万 - 项目类别:
相似海外基金
DYNBIOTICS - Understanding the dynamics of antibiotics transport in individual bacteria
DYNBIOTICS - 了解抗生素在单个细菌中转运的动态
- 批准号:
EP/Y023528/1 - 财政年份:2024
- 资助金额:
$ 4.39万 - 项目类别:
Research Grant
Engineering Streptomyces bacteria for the sustainable manufacture of antibiotics
工程化链霉菌用于抗生素的可持续生产
- 批准号:
BB/Y007611/1 - 财政年份:2024
- 资助金额:
$ 4.39万 - 项目类别:
Research Grant
Hitting bacteria with a Bam: Lectin-Like Antimicrobials as New Antibiotics
用 Bam 击中细菌:凝集素类抗菌剂作为新型抗生素
- 批准号:
DP230102150 - 财政年份:2023
- 资助金额:
$ 4.39万 - 项目类别:
Discovery Projects
“L-form” bacteria: basic science, antibiotics, evolution and biotechnology
L 型细菌:基础科学、抗生素、进化和生物技术
- 批准号:
FL210100071 - 财政年份:2022
- 资助金额:
$ 4.39万 - 项目类别:
Australian Laureate Fellowships
Systematic identification of synthetic interactions in bacteria towards the next-generation of antibiotics
系统鉴定细菌与下一代抗生素的合成相互作用
- 批准号:
468567 - 财政年份:2022
- 资助金额:
$ 4.39万 - 项目类别:
Operating Grants
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10708102 - 财政年份:2022
- 资助金额:
$ 4.39万 - 项目类别:
Repurposing Gram-positive Antibiotics for Gram-Negative Bacteria using Antibiotic Adjuvants
使用抗生素佐剂重新利用革兰氏阳性抗生素治疗革兰氏阴性菌
- 批准号:
10587015 - 财政年份:2022
- 资助金额:
$ 4.39万 - 项目类别:
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10581945 - 财政年份:2021
- 资助金额:
$ 4.39万 - 项目类别:
Developing novel antibiotics from natural products against resistant bacteria
从天然产物中开发针对耐药细菌的新型抗生素
- 批准号:
2599490 - 财政年份:2021
- 资助金额:
$ 4.39万 - 项目类别:
Studentship
Isolation, identification and characterization of potentially novel antibiotics from rhizospheric bacteria without detectable in vitro resistance
从根际细菌中分离、鉴定和表征潜在的新型抗生素,且体外未检测到耐药性
- 批准号:
10358855 - 财政年份:2021
- 资助金额:
$ 4.39万 - 项目类别: